RUNX3 is strongly implicated as tumor suppressor for gastric cancer and the absence of RUNX3 expression is proposed to be linked to gastric cancer because expression of RUNX3 is not observed in more than 45% of the gastric cancer patients (74, 77, 79). This evidence concerns the gene RUNX3 and neoplasm.